Brian Miller, MD
Vascular Surgery · Saint Paul, MNNPI 1164466074
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $7,725 of the $10,335 with a category attached, or 74.7%. Medtronic accounts for 76.4% of it on its own, with 4 other manufacturers making up the rest. Reporting peaked in 2021 at $8,476 and has fallen 98.1% since, to $161 in 2025.
Across 34 payments — averaging $303.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$8K
- Silk Road Medical, Inc.$2K
- Bolton Medical Inc$147
- W. L. Gore & Associates, Inc.$124
- CSL Behring$20
What the payments were for
- Consulting fees$7,72575%
- Travel & lodging$681%
- Food & beverage$2,46024%
- Education$200%
- Entertainment$611%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 22 | $7,897 |
| Silk Road Medical, Inc. | 8 | $2,146 |
| Bolton Medical Inc | 1 | $147 |
| W. L. Gore & Associates, Inc. | 2 | $124 |
| CSL Behring | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Argyle$6,225
- ENROUTE Transcarotid Neuroprotection System$2,025
- ENHANCE Transcarotid Peripheral Access Kit$2,025
- ENROUTE Transcarotid Stent$1,623
- ENROUTE .014 Guidewire$1,623
- ENROUTE Transcarotid Stent System$403
- ENROUTE 0.014 Guidewire$403
- Chameleon$356
- HawkOne$248
- ENDURANT IIS$176
- IN.PACT Admiral$156
- Relay Plus$147
- GORE TAG Thoracic Branch Endoprosthesis$110
How this compares
$10,335 in reported general payments places this provider in the 75th percentile of 84 vascular surgery providers in Minnesota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XareltoRivaroxaban | 12 | $9,075 |
| Rosuvastatin Calcium | 104 | $1,472 |
| ClopidogrelClopidogrel Bisulfate | 102 | $1,309 |
| Atorvastatin Calcium | 66 | $1,150 |
| Ezetimibe | 22 | $365 |
| Cilostazol | 14 | $301 |
Paid to pharmacies, not to this prescriber.
Other vascular surgery in Saint Paul
- Joel BarbatoSaint Paul$9K
- James DavisSaint Paul$5K
- Lan NguyenSaint Paul$2K
- Jodi GerdesSaint Paul$2K
- Todd RasmussenRochester$561K
- Matthew MelinRochester$196K
- Jesse ManungaMinneapolis$95K
- Joseph KaramMinneapolis$88K
- Derrick GreenMinneapolis$37K
- Fahad ShujaRochester$34K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.